Tomáš Hanke - Concepedia

Author

Tomáš Hanke

Also Known As

Edmund G. Wee, Hanke, T, Hanke, T., Hanke, Tom, Hongbing Yang, McMichael, Andrew, T Hanke, T. Hanke, TOMÀŠ HANKE, Tomas Hanke

218

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

University of Oxford MRC Human Immunology Unit Jenner Institute Kumamoto University John Radcliffe Hospital

About

Tomáš Hanke is an author at University of Oxford specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	50	3.4K
2	Allergy	10	10	310
3	Engineering	2	2	158
4	Public Health	2	3	284
5	Applied Physics	1	1	144

Tomáš Hanke

119

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara Jörg Schneider, Sarah C. Gilbert, Tom Blanchard, Nature Medicine VaccinologyVaccinationEnhanced ImmunogenicityVaccine DevelopmentVaccine Target	1998	647
Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen Tomáš Hanke, Rachel V. Samuel, Tom Blanchard, Journal of Virology	1999	306
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine Sven Létourneau, Eung‐Jun Im, Tumelo Mashishi, PLoS ONE	2007	275
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Todd M. Allen, Thorsten U. Vogel, Deborah H. Fuller, The Journal of Immunology	2000	251
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8<sup>+</sup>T-Cell Epitopes Nilu Goonetilleke, S. S. Moore, Len Dally, Journal of Virology	2006	236
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans Matilu Mwau, Inese Cebere, Julian Sutton, Journal of General Virology Mva.hiva VaccinesImmunologyCd4 T Cell ResponsesImmunotherapyVaccine Target	2004	210
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1 Nicola Borthwick, Tina Ahmed, Beatrice Ondondo, Molecular Therapy	2013	200
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. Tomáš Hanke, A J McMichael Nature Medicine VaccinationYear-2000 Clinical TrialImmunologyVaccine TrialVaccine Testing	2000	195
Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1 Louise A. Johnson, Suneale Banerji, William Lawrance, Nature Immunology InflammationHyaluronan-mediated DockingAngiogenesisCell TraffickingImmunology	2017	187
Long-Range Ordering of Vibrated Polar Disks Christoph A. Weber, Tomáš Hanke, Julien Deseigne, Physical Review Letters Vibrated Polar DisksPolar DisksEngineeringPolarization ImagingPhysics	2013	144

Page 1